The risk for treatment discontinuation in patients with RA was lower among those receiving upadacitinib vs TNFi.
Learn about the clinical implications of rheumatoid factor positivity in psoriatic arthritis and its effect on biologic therapy discontinuation.
The Nature Index 2026 Research Leaders reveal the leading institutions and countries/territories in the natural sciences, health sciences, applied sciences and social sciences, according to their ...
Swelling in the wrist and certain metacarpophalangeal joints may resolve slower than that in other joints after starting ...
Announcing a new publication for Acta Materia Medica journal. Diacerein, an anthraquinone derivative, is emerging as a promising disease-modifying agent in rheumatoid arthritis (RA), because of its ...
Biosimilar DMARDs offer cost-effective and improved outcomes over leflunomide for RA patients unresponsive to methotrexate. The study used a Markov model with data from 25,099 RA patients to simulate ...
Subcutaneous tocilizumab, alone or with methotrexate, showed superior efficacy over methotrexate monotherapy in treating rheumatoid arthritis in Chinese patients. The trial demonstrated higher ACR20 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results